Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population

被引:39
作者
Kim, TG
Kim, HY
Lee, SH
Cho, CS
Park, SH
Choi, HB
Han, H
Kim, DJ
机构
[1] CATHOLIC UNIV MED COLL,DEPT INTERNAL MED,LUPUS CLIN RHEUMATISM CTR KANG NAM,ST MARYS HOSP,SEOUL 137701,SOUTH KOREA
[2] CATHOLIC UNIV MED COLL,DEPT MICROBIOL & IMMUNOL,LUPUS CLIN RHEUMATISM CTR KANG NAM,ST MARYS HOSP,SEOUL 137701,SOUTH KOREA
关键词
D O I
10.1016/0198-8859(95)00170-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To evaluate the association of TNFB NcoI polymorphism with SLE in the Korean population, are investigated the frequencies of the TNFB and HLA-DRB1 alleles in 281 controls and 97 SLE patients, including 56 patients with nephritis and 41 patients without nephritis. The frequency of the TNFB*2 homozygote in SLE was significantly increased over controls (43.3% vs 28.5%, RR = 1.9, p < 0.01). In SLE with nephritis, the TNFB*2 homozygote was more significantly increased (57.1% vs 28.5%, RR = 3.4, p < 0.0001), whereas there was no significant difference between SLE without nephritis and controls. The study of HLA-DRB1 alleles revealed the increased frequencies of DRB1*02 and *03 (30.9% vs 18.2%, RR = 2.0, p < 0.01; 8.2% vs 2.1%, RR = 4.1, p < 0.05). There was no significantly different distribution of HLA-DRB1 alleles between SLE patients with nephritis and without nephritis. We found positive LD between TNFB*1 and HLA-DRB1*13, and between TNFB*2 and the particular DRB1 allele: *15, *04, and *07 in controls and/or in SLE patients. After stratification for each HLA-DRB1 allele, SLE with nephritis showed a higher frequency of TNFB*2 homozygote compared with the corresponding controls in DRB1*15, *08, and *09 positives. Our results suggest that the TNFB*2 homozygote may be a strong susceptibility gene of SLE with nephritis in the Korean population.
引用
收藏
页码:10 / 17
页数:8
相关论文
共 31 条
[1]   MICROSATELLITE, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM, AND SEQUENCE-SPECIFIC OLIGONUCLEOTIDE TYPING OF THE TUMOR-NECROSIS-FACTOR REGION - COMPARISONS OF THE 4AOHW CELL PANEL [J].
ABRAHAM, LJ ;
MARLEY, JV ;
NEDOSPASOV, SA ;
CAMBONTHOMSEN, A ;
CROUAUROY, B ;
DAWKINS, RL ;
GIPHART, MJ .
HUMAN IMMUNOLOGY, 1993, 38 (01) :17-23
[2]   STUDIES IN FAMILIAL SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ARNETT, FC ;
SHULMAN, LE .
MEDICINE, 1976, 55 (04) :313-322
[3]  
BETTINOTTI MP, 1993, IMMUNOGENETICS, V37, P449
[4]   STUDIES OF TWINS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - REVIEW OF LITERATURE AND PRESENTATION OF 12 ADDITIONAL SETS [J].
BLOCK, SR ;
WINFIELD, JB ;
LOCKSHIN, MD ;
DANGELO, WA ;
CHRISTIAN, CL .
AMERICAN JOURNAL OF MEDICINE, 1975, 59 (04) :533-552
[5]   POLYMORPHISM IN THE TUMOR NECROSIS FACTOR GENE - ASSOCIATION WITH HLA-B AND DR HAPLOTYPES [J].
CHOO, SY ;
SPIES, T ;
STROMINGER, JL ;
HANSEN, JA .
HUMAN IMMUNOLOGY, 1988, 23 (02) :86-86
[6]  
DALFONSO S, 1994, IMMUNOGENETICS, V39, P150
[7]   MOLECULAR MAPPING OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX BY PULSED-FIELD GEL-ELECTROPHORESIS [J].
DUNHAM, I ;
SARGENT, CA ;
TROWSDALE, J ;
CAMPBELL, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7237-7241
[8]   FAMILY STUDY OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - IMPORTANCE OF NULL ALLELES OF C4A AND C4B IN DETERMINING DISEASE SUSCEPTIBILITY [J].
FIELDER, AHL ;
WALPORT, MJ ;
BATCHELOR, JR ;
RYNES, RI ;
BLACK, CM ;
DODI, IA ;
HUGHES, GRV .
BMJ-BRITISH MEDICAL JOURNAL, 1983, 286 (6363) :425-428
[9]   MAJOR HISTOCOMPATIBILITY COMPLEX GENES AND SUSCEPTIBILITY TO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FRONEK, Z ;
TIMMERMAN, LA ;
ALPER, CA ;
HAHN, BH ;
KALUNIAN, K ;
PETERLIN, BM ;
MCDEVITT, HO .
ARTHRITIS AND RHEUMATISM, 1990, 33 (10) :1542-1553
[10]   NCOI RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) OF THE TUMOR NECROSIS FACTOR (TNF-ALPHA) REGION IN 4 AUTOIMMUNE-DISEASES [J].
FUGGER, L ;
MORLING, N ;
RYDER, LP ;
GEORGSEN, J ;
JAKOBSEN, BK ;
SVEJGAARD, A ;
ANDERSEN, V ;
OXHOLM, P ;
PEDERSEN, FK ;
FRIIS, J ;
HALBERG, P .
TISSUE ANTIGENS, 1989, 34 (01) :17-22